Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunct Prednisolone in Tuberculous Lymphadenitis
NCT05861440Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- May 2023
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial in tuberculous lymphadenitis (TBL) comparing Adjunct corticosteroid + SOC with Standard of Care (2 arms). Primary endpoint: reduction rate of paradoxical upgrading reaction at 9 months. Started May 2023; status: recruiting.
02
Drugs
prednisolone
03
Conditions
tuberculous lymphadenitis (TBL)
Beyond the preview
Go deeper on NCT05861440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05861440.